143 related articles for article (PubMed ID: 9006932)
1. Receptor-induced internalization of selective peptidic mu and delta opioid ligands.
Gaudriault G; Nouel D; Dal Farra C; Beaudet A; Vincent JP
J Biol Chem; 1997 Jan; 272(5):2880-8. PubMed ID: 9006932
[TBL] [Abstract][Full Text] [Related]
2. Preparation and binding properties of radioiodinated analogues of dermorphin and deltorphin with high specificity for the mu- and delta-opioid receptors.
Gaudriault G; Zsürger N; Vincent JP
J Neurochem; 1997 Feb; 68(2):813-9. PubMed ID: 9003073
[TBL] [Abstract][Full Text] [Related]
3. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of [D-Ala2,4'-125I-Phe3,Glu4]deltorphin and characterization of its delta opioid receptor binding properties.
Fang L; Knapp RJ; Matsunaga T; Weber SJ; Davis T; Hruby VJ; Yamamura HI
Life Sci; 1992; 51(20):PL189-93. PubMed ID: 1331636
[TBL] [Abstract][Full Text] [Related]
5. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
6. Binding in vivo of selective mu and delta opioid agonists: localization by autoradiography.
Mokhtari M; Tafani JA; Zajac JM
Neuropeptides; 1993 Sep; 25(3):183-91. PubMed ID: 8247256
[TBL] [Abstract][Full Text] [Related]
7. Binding to delta and mu opioid receptors by deltorphin I/II analogues modified at the Phe3 and Asp4/Glu4 side chains: a report of 32 new analogues and a QSAR study.
Schullery SE; Mohammedshah T; Makhlouf H; Marks EL; Wilenkin BS; Escobar S; Mousigian C; Heyl DL
Bioorg Med Chem; 1997 Dec; 5(12):2221-34. PubMed ID: 9459020
[TBL] [Abstract][Full Text] [Related]
8. mu and delta-opioid receptor agonists induce mitogen-activated protein kinase (MAPK) activation in the absence of receptor internalization.
Kramer HK; Simon EJ
Neuropharmacology; 2000 Jul; 39(10):1707-19. PubMed ID: 10884553
[TBL] [Abstract][Full Text] [Related]
9. Dermorphin-based potential affinity labels for mu-opioid receptors.
Choi H; Murray TF; Aldrich JV
J Pept Res; 2003 Jan; 61(1):40-5. PubMed ID: 12472847
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships of dermorphin analogues containing N-substituted amino acids in the 2-position of the peptide sequence.
Schmidt R; Kálmán A; Chung NN; Lemieux C; Horváth C; Schiller PW
Int J Pept Protein Res; 1995 Jul; 46(1):47-55. PubMed ID: 7558596
[TBL] [Abstract][Full Text] [Related]
11. Dermenkephalin and deltorphin I reveal similarities within ligand-binding domains of mu- and delta-opioid receptors and an additional address subsite on the delta-receptor.
Charpentier S; Sagan S; Delfour A; Nicolas P
Biochem Biophys Res Commun; 1991 Sep; 179(3):1161-8. PubMed ID: 1656944
[TBL] [Abstract][Full Text] [Related]
12. Internalization and trafficking of opioid receptor ligands in rat cortical neurons.
Lee MC; Cahill CM; Vincent JP; Beaudet A
Synapse; 2002 Feb; 43(2):102-11. PubMed ID: 11754488
[TBL] [Abstract][Full Text] [Related]
13. Characterization of [125I]AR-M100613, a high-affinity radioligand for delta opioid receptors.
Fraser GL; Labarre M; Godbout C; Butterworth J; Clarke PB; Payza K; Schmidt R
Peptides; 1999 Nov; 20(11):1327-35. PubMed ID: 10612447
[TBL] [Abstract][Full Text] [Related]
14. Endomorphin-1 discriminates the mu-opioid receptor from the delta- and kappa-opioid receptors by recognizing the difference in multiple regions.
Ide S; Sakano K; Seki T; Awamura S; Minami M; Satoh M
Jpn J Pharmacol; 2000 Aug; 83(4):306-11. PubMed ID: 11001176
[TBL] [Abstract][Full Text] [Related]
15. Characterization of delta, kappa, and mu human opioid receptors overexpressed in baculovirus-infected insect cells.
Massotte D; Baroche L; Simonin F; Yu L; Kieffer B; Pattus F
J Biol Chem; 1997 Aug; 272(32):19987-92. PubMed ID: 9242668
[TBL] [Abstract][Full Text] [Related]
16. Heteromerization of Endogenous Mu and Delta Opioid Receptors Induces Ligand-Selective Co-Targeting to Lysosomes.
Derouiche L; Pierre F; Doridot S; Ory S; Massotte D
Molecules; 2020 Sep; 25(19):. PubMed ID: 33007971
[TBL] [Abstract][Full Text] [Related]
17. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
[TBL] [Abstract][Full Text] [Related]
18. Modification of the Phe3 aromatic moiety in delta receptor-selective dermorphin/deltorphin-related tetrapeptides. Effects on opioid receptor binding.
Heyl DL; Mosberg HI
Int J Pept Protein Res; 1992 May; 39(5):450-7. PubMed ID: 1330964
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacology of halogenated δ-opioid-selective [d-Ala(2)]deltorphin II peptide analogues.
Pescatore R; Marrone GF; Sedberry S; Vinton D; Finkelstein N; Katlowitz YE; Pasternak GW; Wilson KR; Majumdar S
ACS Chem Neurosci; 2015 Jun; 6(6):905-10. PubMed ID: 25844930
[TBL] [Abstract][Full Text] [Related]
20. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception.
Cahill CM; Morinville A; Lee MC; Vincent JP; Collier B; Beaudet A
J Neurosci; 2001 Oct; 21(19):7598-607. PubMed ID: 11567050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
